FDA
Elvitegravir, Cobicistat, Emtricitabine and Tenofovir Alafenamide
The FDA lists this product in 5 strengths and forms.
Composition
- Active ingredients
- ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 200MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 120MG · TabletANDA218575-006 · Tentative approval
- ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 6MG · TabletANDA218575-004 · Tentative approval
- ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 150MG · TabletANDA218575-002 · Tentative approval
- ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 90MG · TabletANDA218575-005 · Tentative approval
- ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 200MG · TabletThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA218575.